Discontinuation report SINGULAIR
| Report ID | 272220 |
| Drug Identification Number | 02247997 |
| Brand name | SINGULAIR |
| Common or Proper name | montelukast granules for oral use |
| Company Name | ORGANON CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | MONTELUKAST |
| Strength(s) | 4MG |
| Dosage form(s) | GRANULES |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| ATC code | R03DC |
| ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2025-12-19 |
| Actual discontinuation date | 2025-12-01 |
| Remaining supply date | 2025-12-19 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16766 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-844-820-5468 dpoc.canada@organon.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-12-03 | French | Compare |
| v3 | 2025-12-03 | English | Compare |
| v2 | 2025-11-19 | French | Compare |
| v1 | 2025-11-19 | English | Compare |
Showing 1 to 4 of 4